Hospira, Inc.

Products

Recalls by Hospira, Inc.

• D-1815-2015 Sep 30, 2015 · Class II
  Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.
• D-1234-2014 Apr 23, 2014 · Class I
  Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.
• D-023-2014 Dec 11, 2013 · Class II
  Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.
• D-926-2013 Sep 4, 2013 · Class II
  Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.
• D-851-2013 Aug 14, 2013 · Class II
  Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot
• D-215-2013 Apr 3, 2013 · Class III
  CGMP Deviations: Shipment of product not approved for release.
• D-169-2013 Mar 6, 2013 · Class II
  Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial
• D-099-2013 Dec 26, 2012 · Class II
  Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter…
• D-096-2013 Dec 26, 2012 · Class II
  Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.
• D-1390-2012 Jun 27, 2012 · Class III
  Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.
• D-1382-2012 Jun 20, 2012 · Class II
  Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel